Statins in lymphangioleiomyomatosis: A word of caution

European Respiratory Journal

Volumn 34, Issue 2, 2008, Pages 513-514

  El Chemaly, S ^a   Taveira DaSilva, A ^a   Stylianou, M P ^a   Moss, J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULOTROPIN D;

ADULT; AGE DISTRIBUTION; ANTINEOPLASTIC ACTIVITY; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; DRUG UTILIZATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LYMPHANGIOGENESIS; LYMPHANGIOLEIOMYOMATOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

ADULT; CHOLESTEROL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LUNG; LYMPHANGIOLEIOMYOMATOSIS; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 69249137543     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00012709     Document Type: Letter

References (7)

1. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-151.
2. Finlay GA, Malhowski AJ, Liu Y, et al. Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. Cancer Res 2007; 67: 9878-9886.
3. Moses MA, Harper J, Folkman J. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs. N Engl J Med 2006; 354: 2621-2622.
4. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004; 126: 1867-1874.
5. Fernandez AB, Karas RH, Alsheikh-Ali AA, et al. Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports. Chest 2008; 134: 824-830.
6. +/- mice. Am J Respir Crit Care Med 2008; 177: A130.
7. Loboda A, Jazwa A, Jozkowicz A, et al. Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin. Vascul Pharmacol 2006; 44: 206-214.